Richard R. Lesniewski

2.1k total citations · 1 hit paper
30 papers, 1.5k citations indexed

About

Richard R. Lesniewski is a scholar working on Hepatology, Epidemiology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Richard R. Lesniewski has authored 30 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Hepatology, 16 papers in Epidemiology and 14 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Richard R. Lesniewski's work include Hepatitis C virus research (22 papers), Hepatitis B Virus Studies (14 papers) and Monoclonal and Polyclonal Antibodies Research (14 papers). Richard R. Lesniewski is often cited by papers focused on Hepatitis C virus research (22 papers), Hepatitis B Virus Studies (14 papers) and Monoclonal and Polyclonal Antibodies Research (14 papers). Richard R. Lesniewski collaborates with scholars based in United States, United Kingdom and Australia. Richard R. Lesniewski's co-authors include Suresh M. Desai, R.H. Miller, Harvey J. Alter, Sugantha Govindarajan, Ronald E. Engle, Patrizia Farci, Doris C. Wong, Norio Ogata, David R. Gretch and Robert L. Carithers and has published in prestigious journals such as Science, Blood and The Journal of Immunology.

In The Last Decade

Richard R. Lesniewski

29 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Lack of Protective Immunity Against Reinfection with Hepatitis C Virus

1992 606 citations Patrizia Farci, Harvey J. Alter et al. Science profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Richard R. Lesniewski United States	18	1.3k	1.1k	269	178	149	30	1.5k
C Bréchot France	14	1.4k 1.1×	1.2k 1.1×	139 0.5×	275 1.5×	226 1.5×	36	1.7k
Shu Kikuchi Japan	10	1.1k 0.8×	802 0.7×	221 0.8×	282 1.6×	86 0.6×	24	1.6k
Hideharu Harada Japan	13	1.3k 1.0×	984 0.9×	232 0.9×	260 1.5×	131 0.9×	26	1.6k
Vicky M.-H. Sung United States	12	1.1k 0.8×	784 0.7×	155 0.6×	300 1.7×	151 1.0×	14	1.6k
Anna Shavinskaya France	3	692 0.5×	554 0.5×	131 0.5×	327 1.8×	64 0.4×	3	1.0k
Daisuke Akazawa Japan	16	658 0.5×	522 0.5×	151 0.6×	210 1.2×	75 0.5×	25	906
Daniel J. Felmlee United Kingdom	17	818 0.6×	735 0.7×	61 0.2×	129 0.7×	178 1.2×	34	1.0k
Noriyoshi Kuzushita Japan	21	697 0.5×	563 0.5×	88 0.3×	200 1.1×	127 0.9×	36	1.3k
Axel Ulsenheimer Germany	17	955 0.7×	851 0.8×	62 0.2×	144 0.8×	87 0.6×	28	1.5k
H. P. Dienes Germany	20	592 0.5×	481 0.4×	103 0.4×	334 1.9×	96 0.6×	50	1.3k

Countries citing papers authored by Richard R. Lesniewski

Since Specialization

Citations

This map shows the geographic impact of Richard R. Lesniewski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard R. Lesniewski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard R. Lesniewski more than expected).

Fields of papers citing papers by Richard R. Lesniewski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard R. Lesniewski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard R. Lesniewski. The network helps show where Richard R. Lesniewski may publish in the future.

Co-authorship network of co-authors of Richard R. Lesniewski

This figure shows the co-authorship network connecting the top 25 collaborators of Richard R. Lesniewski. A scholar is included among the top collaborators of Richard R. Lesniewski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard R. Lesniewski. Richard R. Lesniewski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jiang, Fang, Daniel H. Albert, Yanping Luo, et al.. (2011). ABT-869, a Multitargeted Receptor Tyrosine Kinase Inhibitor, Reduces Tumor Microvascularity and Improves Vascular Wall Integrity in Preclinical Tumor Models. Journal of Pharmacology and Experimental Therapeutics. 338(1). 134–142. 17 indexed citations

Lacy, Susan E., et al.. (2008). The Potency of Erythropoietin-Mimic Antibodies Correlates Inversely with Affinity. The Journal of Immunology. 181(2). 1282–1287. 22 indexed citations

Wang, Gary T., Robert A. Mantei, Megumi Kawai, et al.. (2007). Lead optimization of methionine aminopeptidase-2 (MetAP2) inhibitors containing sulfonamides of 5,6-disubstituted anthranilic acids. Bioorganic & Medicinal Chemistry Letters. 17(10). 2817–2822. 14 indexed citations

Kawai, Megumi, Nwe Y. BaMaung, Steve Fidanze, et al.. (2006). Development of sulfonamide compounds as potent methionine aminopeptidase type II inhibitors with antiproliferative properties. Bioorganic & Medicinal Chemistry Letters. 16(13). 3574–3577. 41 indexed citations

Sheppard, George S., Jieyi Wang, Megumi Kawai, et al.. (2004). 3-Amino-2-hydroxyamides and related compounds as inhibitors of methionine aminopeptidase-2. Bioorganic & Medicinal Chemistry Letters. 14(4). 865–868. 37 indexed citations

Pasquinelli, C, Kyong‐Mi Chang, Luca G. Guidotti, et al.. (1997). Hepatitis C Virus Core and E2 Protein Expression in Transgenic Mice. Hepatology. 25(3). 719–727. 109 indexed citations

Davis, Connie L., David R. Gretch, James D. Perkins, et al.. (1995). Hepatitis c-associated glomerualar disease in liver transplant recipients. Liver Transplantation and Surgery. 1(3). 166–175. 25 indexed citations

Lesniewski, Richard R., et al.. (1995). Expression of HCV envelope proteins and the serological utility of the anti-E2 immune response.. PubMed. 25. 129–37. 4 indexed citations

Lesniewski, Richard R., Richard J. Johnson, James W. Scheffel, et al.. (1995). Antibody to hepatitis C virus second envelope (HCV‐E2) glycoprotein: A new marker of HCV infection closely associated with viremia. Journal of Medical Virology. 45(4). 415–422. 90 indexed citations

10.

Fang, Jane, Gary L. Davis, Robert G. Gish, et al.. (1994). Optimization for the detection of hepatitis C virus (HCV) antigens in the liver. 20. 143–147.

11.

Lau, George, et al.. (1994). Immunoglobulin M and A antibodies to hepatitis C core antigen in chronic hepatitis C virus infection. Journal of Medical Virology. 44(1). 1–4. 9 indexed citations

12.

González‐Peralta, Regino P., Jane Fang, Gary L. Davis, et al.. (1994). Optimization for the detection of hepatitis C virus antigens in the liver. Journal of Hepatology. 20(1). 143–147. 48 indexed citations

13.

Lesniewski, Richard R., et al.. (1993). Localisation of hepatitis C virus proteins in infected liver tissue by immunofluorescence. Gastroenterologia Japonica. 28(S5). 55–58. 9 indexed citations

14.

Rohr, Michael S., et al.. (1993). Risk of Liver Disease in HCV-Seropositive Kidney Transplant Recipients. Annals of Surgery. 217(5). 512–517. 5 indexed citations

15.

Lesniewski, Richard R., et al.. (1993). Hypervariable 5′‐terminus of hepatitis C virus E2/NS1 encodes antigenically distinct variants. Journal of Medical Virology. 40(2). 150–156. 38 indexed citations

16.

Farci, Patrizia, Harvey J. Alter, Sugantha Govindarajan, et al.. (1992). Lack of Protective Immunity Against Reinfection with Hepatitis C Virus. Science. 258(5079). 135–140. 606 indexed citations breakdown →

17.

Bresters, Dorine, H. T. M. Cuypers, H. W. Reesink, et al.. (1992). Enhanced Sensitivity of a Second Generation ELISA for Antibody to Hepatitis C Virus. Vox Sanguinis. 62(4). 213–217. 39 indexed citations

18.

Dawson, George J., et al.. (1991). Detection of antibodies to hepatitis C virus in U.S. blood donors. Journal of Clinical Microbiology. 29(3). 551–556. 67 indexed citations

19.

Chau, Kurt H., George J. Dawson, Robin A. Gutierrez, et al.. (1991). IgM-antibody response to hepatitis C virus antigens in acute and chronic post-transfusion non-A, non-B hepatitis. Journal of Virological Methods. 35(3). 343–352. 30 indexed citations

20.

Mattsson, L., et al.. (1991). Antibodies to Recombinant and Synthetic Peptides Derived from the Hepatitis C Virus Genome in Long-Term-Studied Patients with Posttransfusion Hepatitis C. Scandinavian Journal of Gastroenterology. 26(12). 1257–1262. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact